Prion Diseases pp 161-171 | Cite as

Putting prions into focus: application of single molecule detection to the diagnosis of prion diseases

  • A. Giese
  • J. Bieschke
  • M. Eigen
  • H. A. Kretzschmar
Part of the Archives of Virology. Supplementa book series (ARCHIVES SUPPL, volume 16)


Prion diseases are characterized by the cerebral deposition of an aggregated pathological isoform of the prion protein (PrPSc) which constitutes the principal component of the transmissible agent termed prion. In order to develop a highly sensitive method for the detection of PrPSc aggregates in biological samples such as cerebrospinal fluid (CSF), we used a method based on Fluorescence Correlation Spectroscopy (FCS), a technique which allows detection of single fluorescently labeled molecules in solution. Within the FCS setup, fluorescent photons emitted by molecules passing an open volume element defined by the beam of an excitation laser focussed into a diffraction-limited spot are imaged confocally onto a single photon counting detector. Aggregates of PrPSc could be labeled by co-aggregation of probe molecules such as monomeric recombinant PrP or PrP-specific antibodies tagged with a fluorescent dye. In addition to slow diffusion, labeled aggregates are characterized by high fluorescence intensity, which allows detection and quantification by analysis of fluorescence intensity distribution. To improve detection of rare target particles, the accessible volume element was increased by scanning for intensely fluorescent targets (SIFT). To further improve sensitivity and specificity, two different probes were used simultaneously in a two-color setup. In a diagnostic model system of CSF spiked with purified prion rods, dual-color SIFT was more sensitive than Western blot analysis. In addition, a PrPSc-specific signal was also detected in a number of CSF samples derived from CJD patients but not in controls.


Prion Protein Prion Disease Bovine Spongiform Encephalopathy Fluorescence Correlation Spectroscopy Single Molecule Detection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bessen RA, Marsh RF (1994) Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 68: 7859–7868PubMedGoogle Scholar
  2. 2.
    Bieschke J, Giese A, Schulz-Schaeffef W, Zerr I, Poser S, Eigen M, Kretzschmar HA (2000) Ultra-sensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets. Proc Natl Acad Sci USA 97: 5468–5473PubMedCrossRefGoogle Scholar
  3. 3.
    Brown P, Gibbs CJ Jr, Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A, Goldfarb LG, Gajdusek DC (1994) Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 35: 513–529PubMedCrossRefGoogle Scholar
  4. 4.
    Bruce ME, Will RG, Ironside JW, McConnell I, Drummond P, Suttie A, McCardle L, Chree A, Hope J, Birkett C, Cousens S, Fraser H, Bostock CJ (1997) Transmissions to mice indicate that new variant CJD is caused by the BSE agent. Nature 389: 498–501PubMedCrossRefGoogle Scholar
  5. 5.
    Caughey B, Kocisko DA, Raymond GJ, Lansbury PT Jr (1995) Aggregates of scrapie-associated prion prptein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state. Chem Biol 2: 807–817PubMedCrossRefGoogle Scholar
  6. 6.
    Chen Y, Muller JD, So PT, Gratton E (1999) The photon counting histogram in fluorescence fluctuation spectroscopy. Biophys J 77: 553–567PubMedCrossRefGoogle Scholar
  7. 7.
    Eigen M, Rigler R (1994) Sorting single molecules: application to diagnostics and evolutionary biotechnology. Proc Natl Acad Sci USA 91: 5740–5747PubMedCrossRefGoogle Scholar
  8. 8.
    Eigen M (1996) Prionics or the kinetic basis of prion diseases. Biophys Chem 63: Al–18CrossRefGoogle Scholar
  9. 9.
    Ghani AC, Ferguson NM, Donnelly CA, Hagenaars TJ, Anderson RM (1998) Estimation of the number of people incubating variant CJD. Lancet 352: 1353–1354PubMedCrossRefGoogle Scholar
  10. 10.
    Kascsak RJ, Rubenstein R, Merz PA, Tonna-DeMasi M, Fersko R, Carp RI, Wisniewski HM, Diringer H (1987) Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 61: 3688–3693PubMedGoogle Scholar
  11. 11.
    Krasemann S, Groschup MH, Harmeyer S, Hunsmann G, Bodemer W (1996) Generation of monoclonal antibodies against human prion proteins in PrP0/0 mice. Mol Med 2: 725–734PubMedGoogle Scholar
  12. 12.
    Kuczius T, Groschup MH (1999) Differences in proteinase K resistance and neuronal deposition of abnormal prion proteins characterize bovine spongiform encephalopathy (BSE) and scrapie strains. Mol Med 5: 4O6–418Google Scholar
  13. 13.
    Masel J, Jansen VA, Nowak MA (1999) Quantifying the kinetic parameters of prion replication. Biophys Chem 77: 139–152PubMedCrossRefGoogle Scholar
  14. 14.
    Meyer RK, McKinley MP, Bowman KA, Braunfeld MB, Barry RA, Prusiner SB (1986) Separation and properties of cellular and scrapie prion proteins. Proc Natl Acad Sci USA 83: 2310–2314PubMedCrossRefGoogle Scholar
  15. 15.
    Pan K-M, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE, Prusiner SB (1993) Conversion of α-helices into ß-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 90: 10962–10966PubMedCrossRefGoogle Scholar
  16. 16.
    Pitschke M, Prior R, Haupt M, Riesner D (1998) Detection of single amyloid beta-protein aggregates in the cerebrospinal fluid of Alzheimer’s patients by fluorescence correlation spectroscopy. Nature Med 4: 832–834PubMedCrossRefGoogle Scholar
  17. 17.
    Prusiner SB, McKinley MP, Bowman KA, Bolton DC, Bendheim PE, Groth DF, Glenner GG (1983) Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35: 349–358PubMedCrossRefGoogle Scholar
  18. 18.
    Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95: 13363–13383PubMedCrossRefGoogle Scholar
  19. 19.
    Rigler R, Mets Ü, Widengren J, Kask P (1993) Fluorescence correlation spectroscopy with high count rate and low background: analysis of translational diffusion. Eur Biophys J 22: 169–173CrossRefGoogle Scholar
  20. 20.
    Schwüle P, Bieschke J, Oehlenschläger F (1997) Kinetic investigations by fluorescence correlation spectroscopy: the analytical and diagnostic potential of diffusion studies. Biophys Chem 66: 211–228CrossRefGoogle Scholar
  21. 21.
    Schwüle P, Meyer-Almes FJ, Rigler R (1997) Dual-color fluorescence cross-correlation spectroscopy for multicomponent diffusional analysis in solution. Biophys J 72: 1878–1886CrossRefGoogle Scholar
  22. 22.
    Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347: 921–925PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2000

Authors and Affiliations

  • A. Giese
    • 1
  • J. Bieschke
    • 2
  • M. Eigen
    • 2
  • H. A. Kretzschmar
    • 1
  1. 1.Department of NeuropathologyUniversity of GöttingenGöttingenGermany
  2. 2.Max-Planck-Institute for Biophysical ChemistryGöttingenGermany

Personalised recommendations